Marked variation in oxycodone pharmacokinetics in infants

Paediatric Anaesthesia

Volumn 15, Issue 7, 2005, Pages 560-565

  Pokela, Marja Leena ^a   Anttila, Eija ^b   Seppälä, Timo ^c   Olkkola, Klaus T ^c,d  

^a UNIVERSITY OF OULU   (Finland)

^b NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Infants; Oxycodone; Pharmacokinetics; Pharmacology

Indexed keywords

MORPHINE; OXYCODONE; PARACETAMOL;

APNEA; ARTICLE; ARTIFICIAL VENTILATION; ASSISTED VENTILATION; BREATHING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; GROUPS BY AGE; HUMAN; HYPOVENTILATION; INFANT; NEWBORN; PEDIATRIC ANESTHESIA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; STEADY STATE;

AGING; ANALGESICS, OPIOID; AREA UNDER CURVE; FEMALE; HALF-LIFE; HUMANS; INFANT; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; MALE; OXYCODONE;

EID: 21444434912     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1460-9592.2005.01571.x     Document Type: Article

References (26)

1. Fiselier T, Monnens L, Moerman E et al. Influence of the stress of venepuncture on basal levels of plasma renin activity in infants and children. Int J Pediatr Nephrol 1983; 4: 181-185.
2. Stang HJ, Gunnar MR, Snellman L et al. Local anesthesia for neonatal circumcision - effects on distress and cortisol response. JAMA 1988; 259: 1507-1511.
3. Pokela M-L. Pain relief can reduce hypoxaemia in distressed neonates during routine treatment procedures. Pediatrics 1994; 93: 379-383.
4. Anand KJS, Menon G, Narsinghani U et al. Systemic analgesic therapy. In: Anand KJS, Stevens BJ, McGrath PJ (eds). Pain in Neonates. Amsterdam: Elsevier, 2000: 159-188.
5. Poyhia R, Vainio A, Kalso E. A review of oxycodone's clinical pharmacokinetics and pharmacodynamics. J Pain Symptom Manag 1993; 8: 63-67.
6. Ishida T, Oguri K, Yoshimura H. Determination of oxycodone metabolites in urines and feces of several mammalian species. J Pharmacobiodyn 1982; 5: 521-525.
7. Poyhia R, Kalso E, Seppala T. Pharmacodynamic interactions of oxycodone and amitriptyline in healthy volunteers. Curr Ther Res 1992; 51: 739-749.
8. Otton SV, Wu D, Joffe RT et al. Inhibition by fluoxetine of cytochrome P450 2D6 activity. Clin Pharmacol Ther 1993; 53: 401-409.
9. Beaver WT, Wallenstein SL, Rogers A et al. Analgesic studies of codeine and oxycodone in patients with cancer; II: comparisons of intramuscular oxycodone with intramuscular morphine and codeine. J Pharmacol Exp Ther 1978; 207: 101-108.
10. Chen ZR, Irvine RJ, Somogyi AA et al. Mu receptor binding of some commonly used opioids and their metabolites. Life Sci 1991; 48: 2165-2171.
11. Pöyhiä R. Opioids in anaesthesia: a questionaire survey in Finland. Eur J Anaesthesiol 1994; 11: 221-230.
12. Olkkola KT, Hamunen K, Seppälä T et al. Pharmacokinetics and ventilatory effects of intravenous oxycodone in postoperative children. Br J Clin Pharmacol 1994; 38: 71-76.
13. Czarnecki ML, Jandrisevits MD, Theiler SC et al. Controlled-release oxycodone for the management of pediatric postoperative pain. J Pain Symptom Manag 2004; 27: 379-386.
14. International Narcotics Control Board. Statistical information on narcotic drugs. In: Narcotic Drugs. New York: United Nations, 2004: 67-283.
15. Kalso E, Vainio A. Morphine and oxycodone hydrochloride in the management of cancer pain, Clin Pharmacol Ther 1990; 47: 639-646.
16. Kokki H, Rasanen I, Reinikainen M et al. Pharmacokinetics of oxycodone after intravenous, buccal, intramuscular and gastric administration in children. Clin Pharmacokinet 2004; 43: 613-622.
17. Barrier G, Attia J, Mayer MN et al. Measurement of postoperative pain and narcotic administration in infants using a new clinical scoring system. Intens Care Med 1989; 15: 37-39.
18. Kalso E, Vainio A, Mattila MJ et al. Morphine and oxycodone in the management of cancer pain: plasma levels determined by chemical and radioreceptor assays. Pharmacol Toxicol 1990; 67: 322-328.
19. Gibaldi M, Perrier D. Pharmacokinetics, 2nd edition. New York: Marcel Dekker, Inc., 1982.
20. Anderson BJ, Meakin GH. Scaling for size: some implications for paediatric anaesthesia dosing. Paediatr Anaesth 2002; 12: 205-219.
21. DuBois D, DuBois EF. A formula to estimate the approximate surface area if height and weight be known. Aral Int Med 1916; 17: 863-871.
22. Pokela M-L, Olkkola KT, Koivisto M et al. Pharmacokinetics and pharmacodynamics of intravenous meperidine in neonates and infants. Clin Pharmacol Ther 1992; 52: 342-349.
23. Pokela M-L, Olkkola KT, Seppälä T et al. Age-related morphine kinetics in infants. Dev Pharmacol Ther 1993; 20: 26-34.
24. Olkkola KT, Maunuksela E-L, Korpela R et al. Kinetics and dynamics of postoperative intravenous morphine in children. Clin Pharmacol Ther 1988; 44: 128-136.
25. Lynn A, Nespeca MK, Bratton SL et al. Clearance of morphine in postoperative infants during intravenous infusion: The influence of age and surgery. Anesth Analg 1998; 86: 958-963.
26. Pöyhiä R, Olkkola KT, Kalso E et al. The pharmacokinetics of oxycodone after intravenous injection in adults. Br J Clin Pharmacol 1991; 32: 516-518.